Vanguard Group’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.89M Sell
1,451,205
-134,463
-8% -$268K ﹤0.01% 3401
2025
Q1
$2.3M Sell
1,585,668
-20,505
-1% -$29.7K ﹤0.01% 3453
2024
Q4
$3.32M Buy
1,606,173
+32,789
+2% +$67.9K ﹤0.01% 3413
2024
Q3
$2.77M Buy
1,573,384
+169,186
+12% +$298K ﹤0.01% 3451
2024
Q2
$20.3M Buy
1,404,198
+41,526
+3% +$600K ﹤0.01% 2561
2024
Q1
$22.7M Sell
1,362,672
-102,168
-7% -$1.7M ﹤0.01% 2539
2023
Q4
$23.5M Buy
1,464,840
+310,973
+27% +$4.99M ﹤0.01% 2518
2023
Q3
$15.5M Buy
1,153,867
+250,200
+28% +$3.37M ﹤0.01% 2658
2023
Q2
$15.5M Buy
903,667
+412,033
+84% +$7.08M ﹤0.01% 2703
2023
Q1
$8.13M Sell
491,634
-209,848
-30% -$3.47M ﹤0.01% 3054
2022
Q4
$11.7M Buy
701,482
+71,728
+11% +$1.2M ﹤0.01% 2881
2022
Q3
$10.8M Buy
629,754
+18,947
+3% +$324K ﹤0.01% 2928
2022
Q2
$6.68M Buy
+610,807
New +$6.68M ﹤0.01% 3215